Dasiglucagon, a next‐generation glucagon analogue, for treatment of severe hypoglycaemia via autoinjector device: results of a phase 3, randomised, double‐blind trial

2021 ◽  
Author(s):  
Timothy S. Bailey ◽  
Julie Willard ◽  
Leslie J. Klaff ◽  
Jenine Yager Stone ◽  
Anita Melgaard ◽  
...  
Keyword(s):  
Severe Hypoglycaemia ◽  
Double Blind Trial ◽  
Next Generation ◽  
Phase 3 ◽  
Double Blind ◽  
Blind Trial

scholarly journals P1.01-112 Phase 3, Randomized, Double-Blind Trial of First-Line Pembrolizumab With or Without Lenvatinib in Metastatic NSCLC: LEAP-007

2019 ◽  
Vol 14 (10) ◽  
pp. S405
Author(s):  
T. Mekhail ◽  
S. Kim ◽  
K. Kubota ◽  
M. González Del Riego ◽  
L. Wu ◽  
...  
Keyword(s):  
Double Blind Trial ◽  
First Line ◽  
Phase 3 ◽  
Double Blind ◽  
Blind Trial ◽  
Metastatic Nsclc
Sign in / Sign up

Export Citation Format

Share Document